Analysis of RBC Properties in Patients with SCD Treated with Lentiglobin Gene Therapy
Sign Up to like & getrecommendations! Published in 2018 at "Blood"
DOI: 10.1182/blood-2018-99-115973
Abstract: Introduction: Gene therapy is a highly promising therapeutic strategy in sickle cell disease (SCD). The Phase 1/2 HGB-205 (NCT02151526) clinical study in France is evaluating the safety and efficacy of LentiGlobin gene therapy, which consists… read more here.
Keywords: lentiglobin gene; gene therapy; hgb 205; patients scd ... See more keywords